Ophthalmology Times Europe, Feb 1, 2012 - Ophthalmology Times Europe

ADVERTISEMENT
Ophthalmology Times Europe, Feb 1, 2012
Cover Features
Fighting glaucoma with neuroprotective agents
By Dr Patrick A. Howson
A pharmacoeconomic argument for neuroprotective agents is discussed
The dilemma with normal tension glaucoma treatment
By Dr Andreas U. Bayer
Curcumin: A possible candidate for neuroprotection in glaucoma?
Glaucoma: What's next?
By Dr David G. Godfrey
Medical treatment needs to address ocular surface disease as well as underlying conditions
Relationship of prostaglandin efficacy with race
Ethnicity does not effect treatment, according to Dr Catherine Birt
Cataract & Refractive
Rasch analysis for patient-reported outcome measures in OSD
By Dr Bradley E. Dougherty
A look at current practices and how Rasch analysis may help guide questionnaire development
Ocular surface contributes to IOL surgery outcomes
By Dr Elizabeth A. Davis
Appropriate preparation of the ocular surface can improve results
Improving visual outcomes of LASIK patients
By Dr Eric Donnenfeld
The identification and treatment of dry eye disease
Tissue treats graft failure
By Dr Jai G. Parekh
Thicker amniotic membrane a promising solution to improve ocular surface outcomes
Retina
NSAID aids anti-VEGF drug
By Dr Christina J. Flaxel
Randomized pilot study suggests possible role for bromfenac treatment in exudative AMD
Glaucoma
Relationship between cataract extraction and IOP
By Professor Petja Vassileva
Cataract extraction could reduce complications in XFS
Effect of phacoemulsification on blebs
By Professor Tomasz Zarnowski
Study shows that phaco can cause IOP increase and alteration to bleb morphology
Product
Product Profiles
Product profiles
REQUEST MEDIA KIT
OTE FAMILY
Visit Ophthalmology Times, our US sister publication
OTE e-NEWSLETTER
Click here